Characterisation of gastrointestinal and thoracic neuroendocrine tumours

被引：0

作者：

Baudin, E. ^{[1
]}

Scoazec, J. -Y. ^{[1
]}

Caramella, C. ^{[1
]}

Leboulleux, S. ^{[1
]}

Caron, O. ^{[1
]}

Deandreis, D. ^{[1
]}

Duvillard, P. ^{[1
]}

Lumbroso, J. ^{[1
]}

de Baere, T. ^{[1
]}

Deschamps, F. ^{[1
]}

Goere, D. ^{[1
]}

Dumont, F. ^{[1
]}

Elias, D. ^{[1
]}

Malka, D. ^{[1
]}

Boige, V. ^{[1
]}

Schlumberger, M. ^{[1
]}

Guigay, J. ^{[1
]}

Planchard, D. ^{[1
]}

Ducreux, M. ^{[1
]}

机构：

[1] Gustave Roussy, Ctr Expert RENATEN Tumeurs Neuroendocrines, F-94805 Villejuif, France

来源：

ONCOLOGIE | 2013年 / 15卷 / 10-11期

关键词：

Neuroendocrine tumours; Prognosis factors; Diagnostic impact; Characterisation; Response to treatment; Multidisciplinary expertise; RENATEN and TENPATH networks; ENETS CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; MANAGEMENT; NEOPLASMS;

D O I：

10.1007/s10269-013-2343-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Once the diagnosis of a neuroendocrine tumour has been made, characterisation is an essential step before therapy. It comes before the decision regarding treatment is made. This requires a multidisciplinary team of experts located in specialist centres that currently make up the RENATEN and TENPATH networks. It is directed by knowledge of the location of the primary tumour and anatomical pathological differentiation. The aim of this characterisation step is to highlight factors that may have an impact on the diagnosis and the prognosis or predict the response to treatment.

引用

页码：505 / 509

页数：5

共 50 条

[21] Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours
Laskaratos, Faidon-Marios
Caplin, Martyn
EJSO, 2019, 45 (01): : 52 - 59
[22] Expression of class III β-tubulin in neuroendocrine tumours of gastrointestinal tract
Jirásek, T
Mandys, V
Viklicky, V
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2002, 40 (03) : 305 - 309
[23] CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours
G. Pelosi
Filippo Fraggetta
Angelica Sonzogni
Nicola Fazio
Alessandra Cavallon
Giuseppe Viale
Virchows Archiv, 2000, 437 : 270 - 274
[24] Presenting Symptoms and Delay in Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumours
Basuroy, Ron
Bouvier, Cathy
Ramage, John K.
Sissons, Maia
Kent, Alexandra
Srirajaskanthan, Raj
NEUROENDOCRINOLOGY, 2018, 107 (01) : 42 - 49
[25] Coexistence of two different neuroendocrine tumours of the gastrointestinal tract and the pancreas
Reusch, J
Keck, AM
Link, KH
Mohr, HH
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (49) : 1472 - 1477
[26] CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours
Pelosi, G
Fraggetta, F
Sonzogni, A
Fazio, N
Cavallon, A
Viale, G
VIRCHOWS ARCHIV, 2000, 437 (03) : 270 - 274
[27] Molecular characterisation of gastrointestinal stromal tumours in a South African population
Baker, Gillian
Babb, Chantal
Schnugh, Desmond
Nayler, Simon
Louw, Melanie
Goedhals, Jacqueline
Bringuier, Pierre-Paul
Blay, Jean-Yves
Willem, Pascale
ONCOLOGY LETTERS, 2013, 5 (01) : 155 - 160
[28] EXPLORING GASTROINTESTINAL SYMPTOMS AND THEIR IMPACT ON QUALITY OF LIFE IN PATIENTS WITH NEUROENDOCRINE TUMOURS
Williams, M.
Reid, K.
Lewis, J.
Christian, A.
Sunderraj, L.
Williams, H.
Rees, A.
Khan, M. S.
GUT, 2016, 65 : A216 - A216
[29] Neuroendocrine tumours involving the gastrointestinal tract: A clinicopathological evaluation of 26 cases
Helal, I.
Chaabane, A.
M'Sakni, I.
Laabidi, B.
Doghri, R.
Yahia, M.
Mansouri, N.
Khadhar, A.
Bougrine, F.
Bouziani, A.
VIRCHOWS ARCHIV, 2015, 467 : S124 - S125
[30] A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours
McMullen, Todd
Al-Jahdali, Akram
de Gara, Christopher
Ghosh, Sunita
McEwan, Alexander
Schiller, Daniel
CANADIAN JOURNAL OF SURGERY, 2017, 60 (03) : 192 - 197

← 1 2 3 4 5 →